脑与神经疾病杂志
腦與神經疾病雜誌
뇌여신경질병잡지
JOURNAL OF BRAIN AND NERVOUS DISEASES
2014年
4期
248-251
,共4页
燕毅男%陈伟荣%崔红丽%李新毅
燕毅男%陳偉榮%崔紅麗%李新毅
연의남%진위영%최홍려%리신의
远志总皂苷%阿尔茨海默病%突触可塑性%神经颗粒素%磷酸化的钙/钙调蛋白依赖性蛋白激酶Ⅱα 亚基
遠誌總皂苷%阿爾茨海默病%突觸可塑性%神經顆粒素%燐痠化的鈣/鈣調蛋白依賴性蛋白激酶Ⅱα 亞基
원지총조감%아이자해묵병%돌촉가소성%신경과립소%린산화적개/개조단백의뢰성단백격매Ⅱα 아기
Tenuigenin%Alzheimer’s disease%Synaptic plasticity%Neurogranin%Phosphorylation of calcium/calmodulin-dependent protein kinase type Ⅱalpha subunit
目的:观察远志总皂苷(TEN)对阿尔茨海默病(AD)模型大鼠海马CA1区神经颗粒素(Ng)以及磷酸化的钙/钙调蛋白依赖性蛋白激酶Ⅱα亚基( pCaMKⅡα)表达的影响,探讨TEN防治AD的作用机制。方法将60只雄性Wistar大鼠随机分为对照组,模型组,TEN低剂量治疗组(12.5mg/ml)和TEN高剂量治疗组(37.5 mg/ml),每组15只,模型组予以腹腔注射 D-半乳糖(D-gal)致衰并联合鹅膏覃氨酸(IBO)定向Meynert基底核损毁法建立AD大鼠模型,TEN低、高剂量治疗组则在造模的同时TEN灌胃治疗8w,对照组则用等体积的生理盐水代替D-gal和IBO。采用免疫组化方法来检测大鼠海马CA1区Ng及pCaMKⅡα的表达。结果模型组大鼠海马CA1区Ng 及pCaMKⅡα平均吸光度值比对照组显著降低( P<0.01);TEN治疗组两组平均吸光度值均较模型组显著增高( P<0.01);且TEN高剂量治疗组(37.5 mg/ml)的平均吸光度值比TEN低剂量治疗组(12.5mg/ml)显著增高(P<0.01)。结论 TEN可显著升高AD模型大鼠海马CA1区Ng 及pCaMKⅡα的表达,且具有剂量依赖性。
目的:觀察遠誌總皂苷(TEN)對阿爾茨海默病(AD)模型大鼠海馬CA1區神經顆粒素(Ng)以及燐痠化的鈣/鈣調蛋白依賴性蛋白激酶Ⅱα亞基( pCaMKⅡα)錶達的影響,探討TEN防治AD的作用機製。方法將60隻雄性Wistar大鼠隨機分為對照組,模型組,TEN低劑量治療組(12.5mg/ml)和TEN高劑量治療組(37.5 mg/ml),每組15隻,模型組予以腹腔註射 D-半乳糖(D-gal)緻衰併聯閤鵝膏覃氨痠(IBO)定嚮Meynert基底覈損燬法建立AD大鼠模型,TEN低、高劑量治療組則在造模的同時TEN灌胃治療8w,對照組則用等體積的生理鹽水代替D-gal和IBO。採用免疫組化方法來檢測大鼠海馬CA1區Ng及pCaMKⅡα的錶達。結果模型組大鼠海馬CA1區Ng 及pCaMKⅡα平均吸光度值比對照組顯著降低( P<0.01);TEN治療組兩組平均吸光度值均較模型組顯著增高( P<0.01);且TEN高劑量治療組(37.5 mg/ml)的平均吸光度值比TEN低劑量治療組(12.5mg/ml)顯著增高(P<0.01)。結論 TEN可顯著升高AD模型大鼠海馬CA1區Ng 及pCaMKⅡα的錶達,且具有劑量依賴性。
목적:관찰원지총조감(TEN)대아이자해묵병(AD)모형대서해마CA1구신경과립소(Ng)이급린산화적개/개조단백의뢰성단백격매Ⅱα아기( pCaMKⅡα)표체적영향,탐토TEN방치AD적작용궤제。방법장60지웅성Wistar대서수궤분위대조조,모형조,TEN저제량치료조(12.5mg/ml)화TEN고제량치료조(37.5 mg/ml),매조15지,모형조여이복강주사 D-반유당(D-gal)치쇠병연합아고담안산(IBO)정향Meynert기저핵손훼법건립AD대서모형,TEN저、고제량치료조칙재조모적동시TEN관위치료8w,대조조칙용등체적적생리염수대체D-gal화IBO。채용면역조화방법래검측대서해마CA1구Ng급pCaMKⅡα적표체。결과모형조대서해마CA1구Ng 급pCaMKⅡα평균흡광도치비대조조현저강저( P<0.01);TEN치료조량조평균흡광도치균교모형조현저증고( P<0.01);차TEN고제량치료조(37.5 mg/ml)적평균흡광도치비TEN저제량치료조(12.5mg/ml)현저증고(P<0.01)。결론 TEN가현저승고AD모형대서해마CA1구Ng 급pCaMKⅡα적표체,차구유제량의뢰성。
Objective To observe the effects of tenuigenin ( TEN) on expression of neurogranin ( Ng) and the phosphorylation of calcium/calmodulin-dependent protein kinasetype Ⅱ-alpha ( pCaMKⅡα) in Alzheimer ’ s disease model rats and its possible mechanism .Methods 60 male Wistar rats were divided randomly into four groups:control group,model group,low-dose TEN treatment group(12.5mg/ml)and high-dose TEN treatment group (37.5 mg/ml),each with 15 rats.Model group,low-dose(12.5mg/ml)and high-dose TEN treatment group (37.5 mg/ml)were made by injecting ibotenic acid into Meynertbasal nuclei of aging rat induced by D -gal.At the same time, low-dose TEN treatment group and high-dose TEN treatment group were respectively administrated by gavage for 8 weeks with 12.5mg/ml and 37.5 mg/ml TEN, and the control group was injected with equal volume of normal saline solution instead of D-gal and IBO .The expressions of Ng and pCaMKⅡαin the hippocampus CA 1 area were measured by immunohistochemistry method.Results Compared with the control group , the average absorbance values of Ng and pCaMKⅡαin the model group were decreased significantly ( P<0.01 ) .Compared with the model group , the average absorbance values of Ng and pCaMKⅡαin low-dose TEN treatment group and high-dose TEN treatment group increased significantly ( P<0.01 ) .The average absorbance values of Ng and pCaMKⅡαin high-dose TEN treatment group(37.5 mg/ml) increased significantly than in low-dose TEN treatment group(12.5mg/ml)(P<0.01). Conclusion TEN can dose-dependently increase the expression of Ng and pCaMKⅡαin the hippocampus CA 1 area of Alzheimer’s disease model rats.